Free Trial

Q2 EPS Forecast for Acadia Healthcare Lowered by Analyst

Acadia Healthcare logo with Medical background
Remove Ads

Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) - Equities researchers at Zacks Research decreased their Q2 2025 earnings estimates for shares of Acadia Healthcare in a research report issued to clients and investors on Thursday, March 13th. Zacks Research analyst Z. Masood now forecasts that the company will post earnings per share of $0.77 for the quarter, down from their prior forecast of $0.94. The consensus estimate for Acadia Healthcare's current full-year earnings is $3.38 per share. Zacks Research also issued estimates for Acadia Healthcare's Q3 2025 earnings at $0.91 EPS, Q2 2026 earnings at $0.82 EPS and Q3 2026 earnings at $0.88 EPS.

A number of other analysts also recently weighed in on the stock. KeyCorp decreased their target price on shares of Acadia Healthcare from $70.00 to $65.00 and set an "overweight" rating for the company in a research report on Monday, March 3rd. Deutsche Bank Aktiengesellschaft raised shares of Acadia Healthcare from a "hold" rating to a "buy" rating and increased their target price for the company from $45.00 to $75.00 in a research report on Thursday, December 12th. StockNews.com downgraded shares of Acadia Healthcare from a "hold" rating to a "sell" rating in a research report on Monday, January 6th. Bank of America reduced their price objective on shares of Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating for the company in a research report on Friday, February 28th. Finally, TD Cowen reduced their price objective on shares of Acadia Healthcare from $70.00 to $66.00 and set a "buy" rating for the company in a research report on Tuesday, January 7th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and five have assigned a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus target price of $56.31.

Remove Ads

Read Our Latest Stock Analysis on Acadia Healthcare

Acadia Healthcare Trading Down 0.4 %

NASDAQ ACHC traded down $0.12 during trading hours on Monday, reaching $29.14. The company's stock had a trading volume of 940,075 shares, compared to its average volume of 1,320,710. The firm has a fifty day simple moving average of $39.20 and a 200-day simple moving average of $47.45. The stock has a market cap of $2.71 billion, a P/E ratio of 9.52, a P/E/G ratio of 1.46 and a beta of 1.38. Acadia Healthcare has a 52 week low of $27.61 and a 52 week high of $82.41. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07.

Institutional Trading of Acadia Healthcare

Several hedge funds have recently bought and sold shares of the business. Phocas Financial Corp. grew its position in Acadia Healthcare by 30.6% in the 4th quarter. Phocas Financial Corp. now owns 94,320 shares of the company's stock valued at $3,740,000 after purchasing an additional 22,095 shares during the period. Public Employees Retirement System of Ohio bought a new position in Acadia Healthcare during the 4th quarter valued at $1,293,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in Acadia Healthcare by 22.0% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 313,709 shares of the company's stock valued at $12,439,000 after acquiring an additional 56,647 shares in the last quarter. Voloridge Investment Management LLC bought a new position in Acadia Healthcare during the 4th quarter valued at $15,770,000. Finally, Squarepoint Ops LLC bought a new position in Acadia Healthcare during the 4th quarter valued at $1,087,000.

About Acadia Healthcare

(Get Free Report)

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.

Recommended Stories

Earnings History and Estimates for Acadia Healthcare (NASDAQ:ACHC)

Should You Invest $1,000 in Acadia Healthcare Right Now?

Before you consider Acadia Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.

While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

 5 Stocks to BUY NOW in April 2025
3 Bank Stocks Defying Market Turmoil—Cheap Options Trades!
Time to Buy SoFi? Fintech’s Next Big Move

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads